Go Beyond Blood Sugars

Our GPO Serves Over 20,000 Clinics Nationwide

Welcome, Medical Providers!

The Diabetes Testing Center™ (DTC) is a specialized service of the largest non-acute care Group Purchasing Organization (GPO) in the U.S., with a membership base of over 20,000 clinics. Since 2010, DTC has been unwavering in our commitment to promoting a 'diabetes-centric' philosophy for people living with diabetes and prediabetes. Today, we serve as a one-stop shop that harnesses the buying power of all of its members at the lowest prices possible, ensuring significant cost savings. Providers can transform patient outcomes using our state-of-the-art diagnostic assessments that are non-invasive, evidence-based, and eligible for CMS reimbursements.

After more than 20 years of anticipation, organizations can now close the diabetic retinopathy care gap using the First Portable FDA-Cleared Handheld AI Fundus Camera for diabetic retinopathy. This groundbreaking handheld fundus camera is taking the medical community by storm! Be one of the first to get this high-demand technology that provides immediate diabetic retinopathy diagnosis in less than 60 seconds, without the need for a specialist or eye dilation. Contact us to see how revolutionize your clinic with our cutting-edge diagnostics and quickly change the level of diabetes care.

CMS Reimbursable Assessments

Diabetes Complications

Evidence-Based Technologies Reduce Diabetes Complications

Consolidated Multispecialty Assessments

Diabetes-Centric Philosophy

The 'diabetes-centric' philosophy is not a one-size-fits-all approach. It is designed to be adaptable, empowering medical clinics of all sizes to focus on managing and treating diabetes-related conditions comprehensively. Larger clinics with multiple medical providers can offer a broader range of diagnostic tests and treatments, while smaller clinics can focus on patient education and simple biometric monitoring like A1C's. This adaptability ensures that various aspects of diabetes care are addressed effectively, regardless of clinic size, providing reassurance that this philosophy is applicable to your specific clinic size.

The main objective  of this philosophy is to manage all facets of a patient's health related to diabetes efficiently. However, if a clinic cannot adopt the full spectrum of the recommended Provider Bundle, focusing on specific areas of diabetes-related conditions can still make an impact, like heart attack/stroke, or peripheral arterial disease, or painful neuropathy and generate revenue equivalent to two, three or four medical providers based on the assessments that usually take 3-5 minutes each. Others need a portable handheld AI fundus camera, operating autonomously, which can provide accurate and immediate diagnoses for diabetic retinopathy in less than 60 seconds, eliminating the need to refer patients to a specialist for screenings. This reimbursable procedure consolidates care, closes the diabetic retinopathy care gap, and improves patient outcomes. The potential for significant improvement in patient outcomes is a reason for hope and optimism.

Implementing the 'diabetes-centric' philosophy is not just about improving patient care, it's also financially rewarding for clinics of all sizes. This financial boost not only enhances a clinic's capacity to offer better patient services but also ensures a significant return on investment, motivating the adoption of our technology. All of our assessments are eligible for Medicare and Medicaid reimbursements, making them accessible to a broad patient base. This potential for financial growth is a reason for motivation.

Start with the Heart

Click here to see which assessments can make a meaningful impact on your practice and patient outcomes.


Identify Health Risks 

Diabetes Testing Centers™ offers a range of comprehensive product bundles or à la carte options tailored to the specific assessments and therapies for various medical specialties. These specialties include primary care, cardiology, endocrinology, podiatry, and more. Each bundle is designed to integrate seamlessly into existing workflows, ensuring that providers can offer targeted, effective care without disruption. This approach helps address the unique needs of patients with diabetes and related conditions, enhancing overall health outcomes.

Each bundle is meticulously crafted to seamlessly integrate into existing workflows, enabling providers to deliver targeted, effective care without interruption. This approach is tailored to meet the unique needs of patients managing diabetes and related conditions, which are often associated with significant morbidities and mortalities that can go unchecked. By incorporating comprehensive assessments and management tools across various medical specialties:

These efforts aim to identify and address these conditions early, leading to improved health outcomes and more efficient care delivery. This efficiency ensures that healthcare providers' time and resources are used effectively, enhancing the overall care experience.

Reduce Morbidities and Mortalities

Long COVID-19 Consequences

Cardiovascular disease is the leading cause of death that affects both men and women. Keep in mind that cardiovascular disease, including heart attacks and strokes, poses the greatest risk to diabetes patients because these events can be fatal, rendering other diabetes-related conditions secondary in importance. People who have had COVID-19 are at an even greater risk today, as the virus can exacerbate cardiovascular issues and lead to complications such as myocarditis and blood clots. Therefore, it's crucial for these individuals to be tested for cardiovascular risk factors. Early identification and management of these risks are essential to prevent heart attacks or strokes, which could be life-threatening and overshadow other diabetes-related conditions. 

Our CardioANS test is used by healthcare providers to evaluate their patient's risk of mortality and major adverse cardiovascular events (MACE). The CardioANS graphs the heartbeat as it moves through systolic and diastolic cycles. It tracks deviations in fingertip pressure caused by flexible arteries and produces a tight, regular graph for stiff arteries. Using a proprietary algorithm, the device analyses arterial pulse wave variations and compares them against a large body of research to accurately assess arterial hardening. 

Individuals with Long COVID, especially those with cardiovascular symptoms, should be tested in primary care to determine if comprehensive imaging studies like echocardiograms are needed to evaluate the left ventricle. Monitoring the left ventricle is crucial for developing interventions to address the virus's lasting cardiovascular effects. Additionally, cognitive assessments should be conducted to evaluate cognitive function and provide appropriate care for "brain fog" experienced by post-COVID patients.

Features of the tests:

The Framingham Heart Study found that individuals with asymptomatic left ventricular systolic dysfunction (LVSD) had nearly 5x increase in the risk of developing symptomatic heart failure (HF) compared to those with normal left ventricular function.

Kannel WB, Gordon T, and National Heart Institute (U.S.) (1968) The Framingham study: An epidemiological investigation of cardiovascular disease. Bethesda, MD., United States. Department of Health, Education, and Welfare, National Institutes of Health.

NEW Therapy

FDA Cleared Prefabricated Oral Appliance

 Same Day Therapy

Introducing ApneaReliefMD, our customized Sleep Apnea Solution designed for medical clinics with MDs, DOs, NPs, and PAs. This program specifically manages obstructive sleep apnea (OSA) using Oral Appliance Therapy (OAT). Our comprehensive solution optimizes patient sleep health while maximizing revenue opportunities, providing the support needed to deliver the best care. With ApneaReliefMD™, you can provide high-quality care to your patients while also maximizing your clinic's revenue potential, making it a cost-effective solution for managing OSA.

Medical providers can refer CPAP to a DME company or offer OAT directly. OAT is a comprehensive solution utilizing custom-fitted oral appliances, prioritizing patient comfort and convenience. This thorough approach ensures that all aspects of the patient's sleep health are considered, making medical professionals feel that they are providing a thorough solution. Unlike CPAP machines, OAT devices are discreet, portable, and silent, encouraging greater adherence to therapy and improving outcomes for individuals with OSA. By effectively addressing OSA, OAT supports better health outcomes for individuals with diabetes and prediabetes.

Silent, Comfortable, and Portable 

First, Do No Harm.

Oral Appliance Therapy (OAT) provides a patient-friendly alternative to CPAP for mild and moderate obstructive sleep apnea (OSA). It involves using prefabricated or custom-lab oral appliances that are comfortable, portable, and quiet. OAT improves compliance and leads to better results, making it a preferred first-line therapy for OSA due to its effectiveness. 

Medical providers are instrumental in assisting patients with managing Obstructive Sleep Apnea (OSA) by prioritizing patient comfort and ease of use. By doing so, they help ensure patients stay engaged in their treatment. One approach is to begin with an affordable prefabricated oral appliance for a 1-2 week titration period before contemplating the use of a customized lab-made oral appliance. This method allows for a gradual and cost-effective approach to finding the most suitable and effective treatment for the individual patient.

CPAP Failures and Low Compliance Harms Patients with OSA

Invest in Yourself